Julian KlymochkoAccelerate Monthly - Why Gold Shines Bright in Investment PortfoliosJuly 13, 2024 — While investors’ attention has been recently focused on themes such as artificial intelligence plays (notably GPU supplier…Jul 13Jul 13
Julian KlymochkoAlphaRank Merger Monitor - Deal Drama, Disputes, and DelaysJune 25, 2024 — In last month’s Merger Monitor, Hipster Antitrust, we discussed the FTC’s aggressive approach to antitrust regulations. We…Jun 25Jun 25
Julian KlymochkoActionable Stock Ideas - AlphaRank Top Stocks for JuneJune 22, 2024 — Stock market breadth, which analyzes the number of stocks advancing versus the number of stocks declining, is a…Jun 23Jun 23
Julian KlymochkoAccelerate Monthly - Scoring Big: Caitlin Clark’s Stardom and Nvidia’s StockJune 15, 2024 — In every generation, an athlete comes along whose skill, personality, and resulting popularity transcend the sport.Jun 15Jun 15
Julian KlymochkoHipster AntitrustMay 28, 2024 — Hipster Antitrust is a novel antitrust philosophy that challenges the traditional consumer welfare standard, which has…May 28May 28
Julian KlymochkoAccelerate Monthly - Why Private Credit? The Rising Appeal for Diversified InvestorsMay 14, 2024 — The practice of lending goes back thousands of years, with loans representing one of humanity’s first investable asset…May 14May 14
Julian KlymochkoDecoding the M&A Spree: What’s Next for the Merger Market?April 29, 2024 — What began as a robust merger market, with North American M&A deal announcements averaging twenty per month in the first…Apr 29Apr 29
Julian KlymochkoActionable Stock Ideas - AlphaRank Top Stocks for AprilApril 14, 2024 — Monetary policy has been at the top of investors’ minds this year, as the Fed’s much-expected rate cutting cycle seems to…Apr 14Apr 14
Julian KlymochkoAccelerate Monthly - Investing in a Post-Fundamental WorldApril 7, 2024 — The North Star, also known as Polaris, is a prominent star that has held significant importance throughout history for its…Apr 7Apr 7
Julian KlymochkoSynergies in Science: Exploring Biotech M&A DynamicsMarch 31, 2024 — The pharmaceutical industry is constantly under pressure to innovate and develop new medicines to address society’s unmet…Mar 31Mar 31